DeepMed Research

GLWL-01

Generic Name: GLWL-01

Clinical Trials

Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder

Phase 1

Completed

Conditions: Alcohol Use Disorder

Interventions: Other: Placebo
Drug: GLWL-01

First Posted Date: 2019-04-01

Last Posted Date: 2025-01-15

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 21

Registration Number: NCT03896516

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery (BARI-INSIGHT)

Not Applicable

Completed

Conditions: Obesity
Bariatric Surgery Candidate
Appetitive Behavior

Interventions: Drug: GLWL-01
Other: Placebo

First Posted Date: 2018-08-22

Last Posted Date: 2020-05-20

Lead Sponsor: University College, London

Target Recruit Count: 35

Registration Number: NCT03641417

Locations: 🇬🇧
University College London, London, United Kingdom

A Study of GLWL-01 in Patients With Prader-Willi Syndrome

Phase 2

Completed

Conditions: Prader-Willi Syndrome

Interventions: Drug: GLWL-01
Drug: Placebo

First Posted Date: 2017-09-07

Last Posted Date: 2020-03-27

Lead Sponsor: GLWL Research Inc.

Target Recruit Count: 19

Registration Number: NCT03274856

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇨🇦
CRCHUM, Montreal, Quebec, Canada
🇨🇦
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada

and more 4 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy